These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23986138)

  • 1. Periodontal pathogens and reactivation of latent HIV infection: a review of the literature.
    Jordan L
    J Dent Hyg; 2013 Apr; 87(2):59-63. PubMed ID: 23986138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS.
    Huang CB; Alimova YV; Ebersole JL
    Cell Immunol; 2011; 268(2):105-11. PubMed ID: 21420664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells.
    Huang CB; Emerson KA; Gonzalez OA; Ebersole JL
    Oral Microbiol Immunol; 2009 Oct; 24(5):401-7. PubMed ID: 19702954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral infectious diseases: a potential risk factor for HIV virus recrudescence?
    González OA; Ebersole JL; Huang CB
    Oral Dis; 2009 Jul; 15(5):313-27. PubMed ID: 19364391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-α to reactivate HIV-1 from latency.
    Ren XX; Ma L; Sun WW; Kuang WD; Li TS; Jin X; Wang JH
    Virulence; 2017 Nov; 8(8):1732-1743. PubMed ID: 28762863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages.
    González OA; Ebersole JL; Huang CB
    Mol Oral Microbiol; 2010 Apr; 25(2):136-49. PubMed ID: 20331801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial interaction of periodontopathic bacterium Porphyromonas gingivalis and HIV-possible causal link of periodontal diseases to AIDS progression-.
    Imai K; Victoriano AF; Ochiai K; Okamoto T
    Curr HIV Res; 2012 Apr; 10(3):238-44. PubMed ID: 22384843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation.
    Moriuchi H; Moriuchi M; Mizell SB; Ehler LA; Fauci AS
    J Infect Dis; 2000 Jun; 181(6):2041-4. PubMed ID: 10837189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Interaction Between HIV and Periodontopathic Bacteria That Reactivates HIV Replication in Latently Infected Cells.
    Imai K
    Methods Mol Biol; 2021; 2210():207-214. PubMed ID: 32815141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells.
    Huang CB; Alimova YV; Strange S; Ebersole JL
    Immunology; 2011 Mar; 132(3):401-9. PubMed ID: 21073452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification.
    Imai K; Ochiai K; Okamoto T
    J Immunol; 2009 Mar; 182(6):3688-95. PubMed ID: 19265147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
    Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
    J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell type-specific HIV-1 activation in effector T cells: implications for latent HIV-1 reservoir establishment.
    van der Sluis RM; van Capel TM; Speijer D; Sanders RW; Berkhout B; de Jong EC; Jeeninga RE; van Montfort T
    AIDS; 2015 Jun; 29(9):1003-14. PubMed ID: 25768834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal disease may reactivate latent HIV.
    AIDS Patient Care STDS; 2009 May; 23(5):400-1. PubMed ID: 19422068
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of immune-modulating compounds to disrupt HIV latency.
    Remoli AL; Marsili G; Battistini A; Sgarbanti M
    Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutics for HIV-1 reactivation from latency.
    Sgarbanti M; Battistini A
    Curr Opin Virol; 2013 Aug; 3(4):394-401. PubMed ID: 23810462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent.
    Badia R; Grau J; Riveira-Muñoz E; Ballana E; Giannini G; Esté JA
    Antiviral Res; 2015 Nov; 123():62-9. PubMed ID: 26348004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
    Van Lint C; Quivy V; Demonté D; Chariot A; Vanhulle C; de Walque S; Gaudray G; Veithen E; Bours V; Piette J; Burny A
    Bull Mem Acad R Med Belg; 2004; 159(Pt 2):176-89. PubMed ID: 15615091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.